baber/WOPTO huggingface dataset:
Patent NZ-281536-A (NZ)
Title: Laminating a thermoplastics sheet onto an inner fluid permeable member wherein a fluid pressure differential between the sheet and member is maintained until the sheet has cooled
Inventor: MATICH FRANK ANTHONY
IPC: B29C70/84
Filed: 1995-02-28
Abstract: PCT No. PCT/AU95/00100 Sec. 371 Date Mar. 29, 1996 Sec. 102(e) Date Mar. 29, 1996 PCT Filed Feb. 28, 1995 PCT Pub. No. WO95/23682 PCT Pub. Date Sep. 8, 1995The present invention discloses structural articles such as helmets, cooler chests, pallets, building boards and a large number of diverse articles all formed from an inner, preferably air permeable, body to which a structural strength imparting skin or layer has been applied to either a single surface or opposite surfaces. The body can be expanded polystyrene, wood, particle board, cellulosic fiber cement, GECET or CARIL. The sheet or skin can be acrylonitrile butadiene styrene (ABS), polyester, styrene, or polycarbonate. Amorphous polyester (APET) is particularly preferred. A method of forming such structural articles and apparatus for use in carrying out the method are also disclosed.
Patent NZ-289459-A (NZ)
Title: Horse saddle with transverse passage for overgirth
Inventor: GOBLET LAURENT
IPC: B68C1/02
Filed: 1995-07-07
Abstract: The saddle is made with a slot (16) passing through it transversely beneath the upper surface (18) of the seat to act as a guide for a girth or belly-band. One or two slots can be employed, situated above the surface of the saddle pad (8) and limited at the top by lengthwise straps fixed to the saddle bow frame and at the bottom by two lengthwise bands. Spacers hold the appropriate gaps between the upper and lower surfaces of the slot(s), which are covered with a material ensuring a suitable degree of slip and retention for the girth/belly-band straps. <IMAGE>
Patent NZ-299501-A (NZ)
Title: Azo pigments and plastics compositions thereof
Inventor: MACPHERSON IAN ALEXANDER
IPC: C08L101/00
Filed: 1996-10-03
Abstract: A plastics composition comprising a high molecular weight material and an effective colouring amount of an azo pigment of formula <CHEM> where M is Mg, Ca, Sr, Ba or Mn or a mixture of two or more thereof, R<1> and R<2> are chlorine or methyl, x is zero or 1, y is zero or 1 and the sum of x and y is 1, with the proviso that when the high molecular weight material is polyvinyl chloride y is zero.
Patent NZ-336044-A (NZ)
Title: 1,4-diazabicyclo[2.2.2]oct-2-ylmethyl benzoate derivatives, their preparation and therapeutic application
Inventor: LOCHEAD ALISTAIR
IPC: A61P25/00
Filed: 1997-12-02
Abstract: A compound, in the form of a pure enantiomer or of a mixture of enantiomers, of general formula (I) is claimed wherein R1 represents a methyl group; X1 represents a hydrogen atom, or OR1 and X1 together form a group of formula -O(CH2)2-, -O(CH2)3-, -O(CH2)2O-, or -O(CH2)3O-; X2 represents a hydrogen atom or an amino group and X3 represents a halogen atom. A pharmaceutical composition containing a compound of formula I useful as a ligand of serotoninergic receptors of the 5-HT3 and/or 5-HT4 types, and act as a 5-HT4 agonist and/or 5-HT3 antagonist is claimed.
Patent NZ-500443-A (NZ)
Title: High rate CDMA wireless communication system encoded control data and encoded information data combined in same signal
Inventor: ODENWALDER JOSEPH P
IPC: H04B1/707
Filed: 1998-05-13
Abstract: A set of individually gain adjusted subscriber channels (402, 404, 411, 415) are formed via the use of a set of orthogonal subchannel codes (Wc, Ws, Wf) having a small number of PN spreading chips per orthogonal waveform period. Data to be transmitted via one of the transmit channels is low code rate error correction encoded and sequence repeated before being modulated with one of the subchannel codes, gain adjusted, and summed with data modulated using the other subchannel codes. The resulting summed data (410, 420) is modulated using a user long code and a pseudorandom spreading code (PN code) and upconverted for transmission. The use of the short orthogonal codes provides interference suppression while still allowing extensive error correction coding and repetition for time diversity to overcome the Raleigh fading commonly experienced in terrestrial wireless systems. The set of sub-channel codes may comprise four Walsh codes, each orthogonal to the remaining codes of the set. The use of four sub-channels is preferred as it allows shorter orthogonal codes to be used, however, the use of a greater number of channels and therefore longer codes is acceptable. Preferably, pilot data is transmitted via a first one of the transmit channels and power control data transmitted via a second transmit channel. The length, or number of chips, in each channel code may be different to further reduce the peak-to-average transmit power for higher rate data transmission.
Patent NZ-501320-A (NZ)
Title: Diagnostic test to identify individuals who have a susceptibility to Type 1 diabetes, a.k.a insulin dependent diabetes mellitis (1DDM)
Inventor: WASMUTH HERMANN ELARD
IPC: G01N33/52
Filed: 1998-02-23
Abstract: A diagnostic test and kit to identify individuals who have susceptibility to an undesired immune response in the presence of beta -casein. In particular, the test and kit are used to identify individuals susceptible to Type 1 diabetes, a.k.a. insulin dependent diabetes melitis (IDDM), induced by a diabetogenic variant of beta -casein. This method of diagnosing the susceptibility of such an individual comprises: reacting a cellular component of the human immune system with an antigen or stimulator in the presence of a p-opioid receptor agonist, and measuring the extent of the modulation of the immune response of the cellular component to the antigen or stimulator by the agonist.
Patent NZ-502870-A (NZ)
Title: Inhaler for powdered medicaments comprising a visual display device to indicate the discharge status of the inhaler
Inventor: MURPHY PAUL A
IPC: A61M11/00
Filed: 1996-06-03
Abstract: Provided is an inhaler from which a powdered medicament can be received by a patient by means of an air stream, where the inhaler comprises a visual display device adapted to display the readiness of the immediate discharge of a medicament dose and/or that the medicament dose has been discharged.  The inhaler comprises a pharmaceutical powder cartridge and a receptacle for a pharmaceutical powder cartridge adapted to a hold a depot of medicament for a large number of doses of powder, the powder cartridge having an integrated metering device which comprises at least one metering cavity for holding a predetermined quantity of the powder, wherein the integrated metering device comprises a metering slide which can be moved at least out of a filling position into an emptying position approximately transversely with respect to the flow direction of the powder into the metering slide and the metering slide is arranged below a reservoir space for storing the powder to flow from the reservoir space into the metering cavity of the metering slide by gravity force, and which comprises a device for activating the metering slide of the integrated metering device of the pharmaceutical powder cartridge at least from a filling position into an emptying position.
Patent NZ-504450-A (NZ)
Title: Mapping function and method of transmitting signalling system 7 (SS7) telecommunications messages over data networks
Inventor: GLITHO ROCH
IPC: H04Q3/00
Filed: 1998-11-27
Abstract: A method of modifying a signaling protocol stack to transmit a Signaling System 7 (SS7) telecommunication signaling message over a data network from an origination node to a destination node with the signaling protocol stack having a Signaling Connection Control Part (SCCP) protocol layer on top of a Message Transfer Protocol (MTP) protocol layer comprises: a) replacing the MTP protocol layer with an Internet Protocol (IP) protocol layer; b) adding a SCCP-IP mapping function between the SCCP protocol layer and the IP protocol layer; c) mapping the SS7 signaling message from the SCCP protocol layer in the origination node into an IP message utilizing the SCCP-IP mapping function; and d) sending the IP message over the data network from the origination node to the destination node.  The step of mapping the SS7 message into the IP message can include: i) mapping the SS7 message address into an IP message address to enable the mapped message to be transported over an IP network to the destination node; ii) mapping MTP primitives into IP primitives to enable the mapped message to transport data over the IP network to the IP message address; and iii) setting a Time To Leave (TTL) IP protocol parameter and a Type of Service (TOS) IP protocol parameter to provide required IP protocol parameters to the mapped message that the SCCP protocol layer cannot transfer from the SS7 signaling message to the SCCP-IP mapping function.
Patent NZ-507949-A (NZ)
Title: C-13 or C-14 labelled fluorescein derivatives and diagnostic compositions
Inventor: OHSHIMA JUNKO
IPC: A61K47/26
Filed: 1999-09-21
Abstract: A 13C or 14C - labeled fluorescein ester compound or salt thereof resulting from a reaction of a 13C or 14C - labeled acid with fluorescein at both or either of the two hydroxyl groups at 3' and 6' position to form an ester linkage is disclosed.  A diagnostic agent thereof is useful for diagnosing pancreatic exocrine function.
Patent NZ-514608-A (NZ)
Title: Storage container comprising a flexible vessel held within an exterior frame by elastic strips
Inventor: CONNOLLY JAMES PATRICK
IPC: B65D90/20
Filed: 2000-04-04
Abstract: An improved portable storage container comprises an exterior support frame (1) defining an interior space having an upper periphery and including upright members (3) spaced around the periphery of the interior space and horizontal elongate members (6) disposed about the upper periphery of the interior space, the elongate members (6) each extending along a corresponding side of a polygon.  A flexible vessel (2) is arranged within the interior space.  The container comprises elastic support means for the upper perimetral portion of the perimetral wall (8) comprising a plurality of strips (10) of elastic material, each extending over a corresponding elongate member (6) of the supporting frame (1), a first end portion (11) of each strip (10) being bonded in a first region of bonding to an inner face of the perimetral wall (8), and a second end portion (12) being bonded in a second region of bonding to an outer face of perimetral wall (8).  In each of the elastic strips (10), the warp threads are less elastic than the weft threads.
Patent NZ-515231-A (NZ)
Title: End closure modules for multi-cell pressure vessels, and pressure vessels and vehicles containing the same
Inventor: WARNER MARK J
IPC: B60K15/03
Filed: 2000-04-26
Abstract: Closure modules that are coupled to and enclose ends of a multi-cell pressure vessel, especially a multi-cell pressure vessel having arcuate outer wall segments connected by internal web segments that define a plurality of cells in the pressure vessel are disclosed. The closure modules each have an arcuate surface portion and at least one interfacing surface portion integrally connected at a marginal extent thereof with a marginal extent of the arcuate surface portion. The arcuate surface and interfacing surface portions define a closure module chamber and have peripheral edges. The arcuate surface portion of one of the closure modules abuts contiguously against an interfacing surface portion of an adjacent one of the closure modules. The closure modules are particularly useful for use with multi-cell tanks and vessel bodies, especially tanks and vessels suitable for storing liquid propane.
Patent NZ-519311-A (NZ)
Title: Indole derivatives as MCP-1 receptor antagonists
Inventor: FAULL ALAN WELLINGTON
IPC: A61P29/00
Filed: 2001-01-09
Abstract: The application relates to a compound of the formula I (see below) wherein: R1 is hydrogen, halo, methyl, ethyl or methoxy; R2 is hydrogen, halo, methyl, ethyl or methoxy; R3 is a halo group, lower alkyl, lower alkenyl, lower alkynyl, alkoxy, trifluoromethyl, nitro, cyano, trifluoromethoxy, C(O)R7, or S(O)nR7 where n is 0,1 or 2 and R7 is an alkyl group; R4 is a halo, trifluoromethyl, methylthio, methoxy, trifluoromethoxy or lower alkyl, lower alkenyl or lower alkynyl; R5 is hydrogen, halo, cyano, lower alkyl, lower alkenyl or lower alkynyl or COR8 where R8 is lower alkyl; R6 is hydrogen, halo, lower alkyl, lower alkenyl, lower alkynyl or COR9 where R9 is lower alkyl; provided that when R1 is hydrogen, halo or methoxy, R2 is hydrogen, halo, methyl, ethyl or methoxy, R5 and R6 are both hydrogen, and one of R3 or R4 is chloro, fluoro, or trifluoromethyl, then the other is not halo or trifluoromethyl; or a pharmaceutically acceptable salt or prodrug thereof. The process for preparing the compound or a pharmaceutical acceptable salt of the compound is also disclosed.
Patent NZ-521559-A (NZ)
Title: Pesticide compositions containing neem seed extracts such as azadirachtins and saccharide
Inventor: DAMARLA SREENIVASA RAO
IPC: A01N25/12
Filed: 2001-04-04
Abstract: A solid free flowing pesticide powder composition containing a neem seed extract and at least one saccharide is disclosed, wherein the neem seed extract contains azadirachtin. This pesticide powder composition is storage stable, has higher pesticidal activity, and can be easily dissolved and/or dispersed in a liquid medium, such as a water-based medium. A method to impart early mortality of an insect, and to increase the growth inhibition rate of an insect in terms of response to this pesticide composition containing a neem seed extract and at least one saccharide is also disclosed.
Patent NZ-525283-A (NZ)
Title: Conditionally replicating vectors, methods for their production and use
Inventor: CHANG YUNG-NIEN
IPC: A61K35/76
Filed: 2001-09-21
Abstract: Disclosed are conditionally replicating reduced recombination lentiviral vectors that have improved safety against the generation of replication competent vectors or virus. Also disclosed are methods of making, propagating and selectively packaging, modifying, and using such vectors. Included are improved helper constructs and host cells, for use with the improved vectors as well as pharmaceutical compositions and host cells comprising the vectors, the use of vector containing host cells to screen drugs, and methods of using the vectors to determine gene function. The methods also include the prophylatic and therapeutic treatment of disease, especially viral infection, and HIV infection in particular.
Patent NZ-527241-A (NZ)
Title: Analogues of GLP-1
Inventor: DONG ZHENG XIN
IPC: A61P25/00
Filed: 1999-12-07
Abstract: A peptide analogue of human glucagon-like peptide-1 (GLP-1) and the use of the analogue in the preparation of a medicament for the treatment of disease such as type I diabetes, type II diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorders, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease. (62) Divided out of 511931
Patent NZ-528710-A (NZ)
Title: Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
Inventor: LEVITZKI ALEXANDER
IPC: A61P35/00
Filed: 2002-03-12
Abstract: Described are radiolabeled epidermal growth factor receptor tyrosine kinase irreversible inhibitors of formula (I) wherein: Q1 is X-Y(=O)-Z and Q2 is H, halogen, alkoxy, hydroxyl, thiohydroxy, thioalkoxy, alkylamino and amino, or; Q2 is X-Y(=O)-Z and Q1 is H, halogen, alkoxy, hydroxyl, thiohydroxy, thioalkoxy, alkylamino and amino; X is selected from -NR1-, -O-, -NH-NR1-, -O-NR1-, -NH-CHR1-, -CHR1-NH-, -CHR1-O-, -O-CHR1-, -CHR1-CH2- and -CHR1-S-, or absent; Y is a radioactive or non-radioactive C; Z is -R2C=CHR3-, -Ca"C=R3, or -R2C=C=CHR3; Ra is hydrogen, or alkyl; A, B, C and D are independently H, a non-radioactive derivatising group or radioactive Br, I or F; Provided the compound comprises at least one radioactive atom. Further described is: a method of synthesizing a radiolabeled compound of formula (I); a pharmaceutical composition with as active ingredient a radiolabeled compound and a pharmaceutical carrier, for use in a medicinal radioimaging method for monitoring the level of epidermal growth factor receptor within the body of a patient, and as radiopharmaceuticals for radiotherapy.
Patent NZ-532046-A (NZ)
Title: A curtain glide or slide
Inventor: REBBECK LEWIS MERVYN
IPC: A47H15/04
Filed: 2004-03-30
Abstract: A curtain glide or slide (1) including a track engaging means (2) and an arm (3) incorporating a hole (4) in which a rivet, button or clip, pressed or pushed through either the fabric or curtain tape fixed to the fabric of a curtain, is engaged. The arrangement of the arm and rivet, button or clip when engaged with the fabric of the curtain supports the curtain relative to the glide or slide.
Patent NZ-533797-A (NZ)
Title: Cytotoxic protein and utilization thereof
Inventor: SAISHO HIROMITSU
IPC: A61P1/00
Filed: 2002-12-05
Abstract: Disclosed is a cytotoxic protein produced by Helicobacter pylori, an antitumor agent containing the protein, and antibodies corresponding to the protein. Also disclosed are methods for detecting the protein using said antibodies, and methods and kits for screening for compounds promoting or inhibiting the said protein.
Patent NZ-534816-A (NZ)
Title: Vehicle suspension
Inventor: DUDDING ASHLEY THOMAS
IPC: B60G7/04
Filed: 2002-02-21
Abstract: A non-torque reactive air suspension exhibiting excellent roll stability characteristics is shown to include frame hangers mounted to frame rails extending longitudinally on opposite sides of a vehicle. Longitudinally extending beams are connected to the frame hangers at one end and extend parallel to the frame rails. At their other ends, the beams are joined by a crossbrace extending laterally across the vehicle centerline. In a central portion thereof, the beams have an axle pivot bore to which an axle clamp assembly is connected, the axle clamp assembly clamping a drive axle housing for the vehicle. The axle pivot bore is generally aligned with the drive axle. A control rod assembly is connected to suspension or frame components. Together with the beams, the control rod assembly forms a parallelogram configuration wherein the beams form the lower linkages of that configuration and the control rods included within the control rod assembly form the upper linkages of that configuration.
Patent NZ-539378-A (NZ)
Title: Authentication of documents and articles by moire patterns
Inventor: HERSCH ROGER D
IPC: G07D7/20
Filed: 2003-09-24
Abstract: The present invention relies on the moirÚ patterns generated when superposing a base layer made of base band patterns and a revealing line grating (revealing layer). The produced moirÚ patterns comprise an enlargement and a transformation of the individual patterns located within the base bands. Base bands and revealing line gratings may be rectilinear or curvilinear. When translating or rotating the revealing line grating on top of the base layer, the produced moirÚ patterns evolve smoothly, i.e. they may be smoothly shifted, sheared, and possibly be subject to further transformations. Base band patterns may incorporate any combination of shapes, intensities and colours, such as letter, digits, text, symbols, ornaments, logos, country emblems, etc. They therefore offer great possibilities for creating security documents and valuable articles taking advantage of the higher imaging capabilities of original imaging and printing systems, compared with the possibilities of the reproduction systems available to potential counterfeiters. Since the revealing line grating reflects a relatively high percentage of the incident light, the moirÚ patterns are easily apparent in reflective mode and under normal illumination conditions. They may be used for the authentication of any kinds of documents (banknotes, identity documents, checks, diploma, travel documents, tickets) and valuable articles (optical disks, CDs, DVDs, CD-ROMs, packages for medical drugs, bottles, articles with affixed labels).
Patent NZ-544887-A (NZ)
Title: Locking device for a telescopic stem of a trolley
Inventor: REFSUM BJORN
IPC: F16B7/14
Filed: 2004-06-25
Abstract: Locking device for a telescopic stem for a trolley wherein the stem comprises an inner stem and an outer stem, which may glide into each other, characterised in that a friction element is arranged in the outer stem and that the inner stem is equipped with the blocking element grasping into the friction element and locking the movement of the inner stem in relation to the outer stem, in that the blocking element presses against the friction element of housing with a conical groove linked to a rod stretching from the housing to the upper end of the inner stem and connected to a handle which influences the position of the housing.
Patent NZ-550136-A (NZ)
Title: Cheetah Muzzle
Inventor: FRANCOIS RICHARD KARL
Filed: 2006-09-27
Abstract: A cheetah muzzle comprising leather straps attached to a face grille made of lightweight stainless steel or titanium measuring 6 cm in width at the front at the front and extending rearwardly away from the front of the grille to maximum width of 8 cm, thereby in use enclosing a cheetah's mouth and reducing the risk of harm to others while allowing the rest of the cheetah's body to move with minimal impairment.
Patent NZ-551053-A (NZ)
Title: Carton and carton blank with frangible connections
Inventor: BLIN PATRICK
IPC: B65D71/38
Filed: 2005-04-08
Abstract: A two part carton 30 comprises an open top container and a separate top closure, where the open top container 30 is formed from a single blank and has a pair of opposed side walls 18 and a pair of opposed end walls 16. At least one of the side and end walls has an integral hinged flap 26 76 at the top of the wall. This flap 26 76 folds down into the container 30. The top closure has a top panel 22 and an engaging tab. When the top flap 26 76 is folded down into the container 30, it will engage with the engaging tab of the top closure such that the top closure will be locked into a recessed position below the top edge of at least one of the walls. This arrangement helps secure the contents of the carton 30 in position.
Patent NZ-554017-A (NZ)
Title: [(Quinazolin-4-yloxy)phenyl]acetamide derivatives
Inventor: PLE PATRICK
IPC: A61K31/517
Filed: 2005-10-07
Abstract: Disclosed are [(quinazolin-4-yloxy)phenyl]acetamide derivatives of Formula I, or a pharmaceutically-acceptable salt, solvate thereof, where X1 is O; each R2 group, which may be the same or different, is selected from halogeno, trifluoromethyl, cyano, hydroxy, amino, alkyl, alkenyl, alkynyl, alkoxy, alkylamino and di-[(1-6C)alkyl]amino; R3-R5 are independently hydrogen, methyl or ethyl; Ring A is a 6-membered monocyclic, a 10-membered bicyclic aryl ring, a 5- or 6-membered monocyclic or a 9- or 10-membered bicyclic heteroaryl ring with up to three ring heteroatoms selected from oxygen, nitrogen and sulphur; the -C(R3)(R4)-CON(R5) group being located at the 4-position relative to the X1 group; and wherein the remaining substituents are as defined herein. Of particular importance is the compound N-(1-isopropylpyrazol-4-yl)-2-[4-(6,7-dimethoxyquinazolin-4-yloxy)phenyl]acetamide. Also disclosed is a pharmaceutical composition containing a compound as defined above for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.